Aktie BALAXI BALAXI PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Balaxi Pharmaceuticals Limited

Aktien

BALAXI

INE618N01014

BALAXI

Markt geschlossen - NSE India S.E.
Andere Börsenplätze
 06:29:47 18.05.2024 		% 5 Tage % 1. Jan.
649 INR +0,06 % Intraday Chart für Balaxi Pharmaceuticals Limited +4,65 % +50,11 %
09.05. Balaxi Pharmaceuticals Limited ernennt Mahesh Inani zum Compliance-Beauftragten CI
08.05. Balaxi Pharmaceuticals Limited kündigt den Rücktritt von Purnima Singh Kamble als unabhängiges Mitglied des Verwaltungsrats an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Balaxi Pharmaceuticals Limited Appoints Mahesh Inani as the Compliance Officer
Balaxi Pharmaceuticals Limited Announces Resignation of Purnima Singh Kamble as Independent Director
Balaxi Pharmaceuticals Limited Announces Resignation of Udayan Shukla as Company Secretary and Compliance Officer
Balaxi Pharmaceuticals Limited Incorporates New Wholly Owned Subsidiary in Chile
Balaxi Pharmaceuticals Limited Announces Update on Company's Pharmaceutical Formulation Plant
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Balaxi Pharmaceuticals Limited agreed to acquire Balaxi Healthcare Ecuador S.A.S. for $0.04 million.
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Balaxi Pharmaceuticals : Certificate under SEBI (Depositories and Participants) Regulations, 2018
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Balaxi Pharmaceuticals : Press Release
Balaxi Pharmaceuticals : Extra Ordinary Meeting
Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. BALAXI Aktie
  4. Nachrichten Balaxi Pharmaceuticals Limited
  5. Andere Sprachen